Karen Sims Arbutus Biopharma Corp (ABUS) insider trading activity

ABUS Quotes by TradingView

Karen Sims is Chief Medical Officer of Arbutus Biopharma Corp. Currently has a direct ownership of 155,494 shares of ABUS, which is worth approximately $531,789. The most recent transaction as insider was on Feb 14, 2025, when has been sold 49,300 shares (Common Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 155K
23.86% 3M change
23.86% 12M change
Total Value Held $531,789

Karen Sims Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 14 2025
BUY
Grant, award, or other acquisition
-
49,300 Added 24.07%
155,494 Common Shares
Feb 04 2025
SELL
Open market or private sale
$63,461 $3.28 p/Share
19,348 Reduced 15.41%
106,194 Common Shares
Feb 02 2024
SELL
Open market or private sale
$10,066 $2.31 p/Share
4,358 Reduced 3.35%
125,542 Common Shares
Feb 01 2024
BUY
Grant, award, or other acquisition
-
101,000 Added 43.74%
129,900 Common Shares
KS

Karen Sims

Chief Medical Officer
Warminster, PA

Track Institutional and Insider Activities on ABUS

Follow Arbutus Biopharma Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ABUS shares.

Notify only if

Insider Trading

Get notified when an Arbutus Biopharma Corp insider buys or sells ABUS shares.

Notify only if

News

Receive news related to Arbutus Biopharma Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ABUS